Metabolic Assessment of Gliomas Using 11C-methionine, [18F] Fluorodeoxyglucose, and 11C-choline Positron-emission Tomography

Overview

Journal AJNR Am J Neuroradiol

Specialty Neurology

Date 2008 Apr 5

PMID 18388218

Citations 77

Authors

T Kato

J Shinoda

N Nakayama

K Miwa

A Okumura

H Yano

S Yoshimura

T Maruyama

Y Muragaki

T Iwama

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Positron-emission tomography (PET) is a useful tool in oncology. The aim of this study was to assess the metabolic activity of gliomas using (11)C-methionine (MET), [(18)F] fluorodeoxyglucose (FDG), and (11)C-choline (CHO) PET and to explore the correlation between the metabolic activity and histopathologic features.

Materials And Methods: PET examinations were performed for 95 primary gliomas (37 grade II, 37 grade III, and 21 grade IV). We measured the tumor/normal brain uptake ratio (T/N ratio) on each PET and investigated the correlations among the tracer uptake, tumor grade, tumor type, and tumor proliferation activity. In addition, we compared the ease of visual evaluation for tumor detection.

Results: All 3 of the tracers showed positive correlations with astrocytic tumor (AT) grades (II/IV and III/IV). The MET T/N ratio of oligodendroglial tumors (OTs) was significantly higher than that of ATs of the same grade. The CHO T/N ratio showed a significant positive correlation with histopathologic grade in OTs. Tumor grade and type influenced MET uptake only. MET T/N ratios of more than 2.0 were seen in 87% of all of the gliomas. All of the tracers showed significantly positive correlations with Mib-1 labeling index in ATs but not in OTs and oligoastrocytic tumors.

Conclusion: MET PET appears to be useful in evaluating grade, type, and proliferative activity of ATs. CHO PET may be useful in evaluating the potential malignancy of OTs. In terms of visual evaluation of tumor localization, MET PET is superior to FDG and CHO PET in all of the gliomas, due to its straightforward detection of "hot lesions".

Citing Articles

Predicting Isocitrate Dehydrogenase Status in Non-Contrast-Enhanced Adult-Type Astrocytic Tumors Using Diffusion Tensor Imaging and C-Methionine, C-Choline, and F-Fluorodeoxyglucose PET.

Yasuda S, Yano H, Ikegame Y, Ikuta S, Maruyama T, Kumagai M Cancers (Basel). 2024; 16(8).

PMID: 38672625 PMC: 11048577. DOI: 10.3390/cancers16081543.

Role of amide proton transfer imaging in maximizing tumor resection in malignant glioma: a possibility to take the place of C-methionine positron emission tomography.

Inoue A, Watanabe H, Kusakabe K, Nishikawa M, Shiraishi Y, Taniwaki M Neurosurg Rev. 2023; 46(1):294.

PMID: 37925381 DOI: 10.1007/s10143-023-02202-1.

Resection of positive tissue on methionine-PET is associated with improved survival in glioblastomas.

Ohmura K, Daimon T, Ikegame Y, Yano H, Yokoyama K, Kumagai M Brain Behav. 2023; 13(12):e3291.

PMID: 37846176 PMC: 10726771. DOI: 10.1002/brb3.3291.

Differentiation of astrocytoma between grades II and III using a combination of methionine positron emission tomography and magnetic resonance spectroscopy.

Yano H, Miwa K, Nakayama N, Maruyama T, Ohe N, Ikuta S World Neurosurg X. 2023; 19:100193.

PMID: 37123626 PMC: 10141501. DOI: 10.1016/j.wnsx.2023.100193.

Tracers progress for positron emission tomography imaging of glial-related disease.

Jia H, Xie T J Biomed Res. 2022; 36(5):321-335.

PMID: 36131689 PMC: 9548440. DOI: 10.7555/JBR.36.20220017.

References

Kapouleas I, Alavi A, Alves W, Gur R, Weiss D . Registration of three-dimensional MR and PET images of the human brain without markers. Radiology. 1991; 181(3):731-9. DOI: 10.1148/radiology.181.3.1947089. View

Schiffer D, Bosone I, Dutto A, Di Vito N, Chio A . The prognostic role of vessel productive changes and vessel density in oligodendroglioma. J Neurooncol. 2000; 44(2):99-107. DOI: 10.1023/a:1006206920822. View

Cairncross J, Ueki K, Zlatescu M, Lisle D, Finkelstein D, Hammond R . Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst. 1998; 90(19):1473-9. DOI: 10.1093/jnci/90.19.1473. View

Utriainen M, Komu M, Vuorinen V, Lehikoinen P, Sonninen P, Kurki T . Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS. J Neurooncol. 2003; 62(3):329-38. DOI: 10.1023/a:1023342516925. View

Levivier M, Massager N, Wikler D, Lorenzoni J, Ruiz S, Devriendt D . Use of stereotactic PET images in dosimetry planning of radiosurgery for brain tumors: clinical experience and proposed classification. J Nucl Med. 2004; 45(7):1146-54. View

Avril N, Menzel M, Dose J, Schelling M, Weber W, Janicke F . Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis. J Nucl Med. 2001; 42(1):9-16. View

Kim S, Chung J, Im S, Jeong J, Lee D, Kim D . 11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET. Eur J Nucl Med Mol Imaging. 2004; 32(1):52-9. DOI: 10.1007/s00259-004-1598-6. View

Schiffer D, Dutto A, Cavalla P, Bosone I, Chio A, Villani R . Prognostic factors in oligodendroglioma. Can J Neurol Sci. 1997; 24(4):313-9. DOI: 10.1017/s0317167100032984. View

De Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M . Positron emission tomography with injection of methionine as a prognostic factor in glioma. J Neurosurg. 2001; 95(5):746-50. DOI: 10.3171/jns.2001.95.5.0746. View

10.

Ogawa T, Inugami A, Hatazawa J, Kanno I, Murakami M, Yasui N . Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine. AJNR Am J Neuroradiol. 1996; 17(2):345-53. PMC: 8338383. View

11.

Plate K, Risau W . Angiogenesis in malignant gliomas. Glia. 1995; 15(3):339-47. DOI: 10.1002/glia.440150313. View

12.

Plate K, Breier G, Risau W . Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol. 1994; 4(3):207-18. DOI: 10.1111/j.1750-3639.1994.tb00835.x. View

13.

Hara T, Kondo T, Hara T, Kosaka N . Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas. J Neurosurg. 2003; 99(3):474-9. DOI: 10.3171/jns.2003.99.3.0474. View

14.

Nariai T, Tanaka Y, Wakimoto H, Aoyagi M, Tamaki M, Ishiwata K . Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma. J Neurosurg. 2005; 103(3):498-507. DOI: 10.3171/jns.2005.103.3.0498. View

15.

Buck A, Schirrmeister H, Kuhn T, Shen C, Kalker T, Kotzerke J . FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters. Eur J Nucl Med Mol Imaging. 2002; 29(10):1317-23. DOI: 10.1007/s00259-002-0880-8. View

16.

Herholz K, Holzer T, Bauer B, Schroder R, Voges J, Ernestus R . 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology. 1998; 50(5):1316-22. DOI: 10.1212/wnl.50.5.1316. View

17.

Derlon J, Chapon F, Beaudouin V, Noel M, Creveuil C, Courtheoux P . The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine. Neurosurgery. 1997; 40(2):276-87; discussion 287-8. DOI: 10.1097/00006123-199702000-00009. View

18.

Narayanan T, Said S, Mukherjee J, Christian B, Satter M, Dunigan K . A comparative study on the uptake and incorporation of radiolabeled methionine, choline and fluorodeoxyglucose in human astrocytoma. Mol Imaging Biol. 2003; 4(2):147-56. DOI: 10.1016/s1536-1632(01)00010-5. View

19.

Tateishi U, Yamaguchi U, Seki K, Terauchi T, Arai Y, Hasegawa T . Glut-1 expression and enhanced glucose metabolism are associated with tumour grade in bone and soft tissue sarcomas: a prospective evaluation by [18F]fluorodeoxyglucose positron emission tomography. Eur J Nucl Med Mol Imaging. 2006; 33(6):683-91. DOI: 10.1007/s00259-005-0044-8. View

20.

Ohtani T, Kurihara H, Ishiuchi S, Saito N, Oriuchi N, Inoue T . Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging. Eur J Nucl Med. 2001; 28(11):1664-70. DOI: 10.1007/s002590100620. View